Insulin Signaling in Insulin Resistance States and Cancer: A Modeling Analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin Signaling in Insulin Resistance States and Cancer: A Modeling Analysis
Authors
Keywords
Insulin, Insulin signaling, Insulin resistance, Phosphorylation, Cell cycle and cell division, Apoptosis, Dose prediction methods, Phosphatases
Journal
PLoS One
Volume 11, Issue 5, Pages e0154415
Publisher
Public Library of Science (PLoS)
Online
2016-05-06
DOI
10.1371/journal.pone.0154415
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation
- (2014) Amira Klip et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Self-consumption: the interplay of autophagy and apoptosis
- (2014) Guillermo Mariño et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Insulin Signaling in Type 2 Diabetes
- (2013) Cecilia Brännmark et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance
- (2013) Serenella Salinari et al. PLoS One
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Regulation of Insulin Signaling and Glucose Transporter 4 (GLUT4) Exocytosis by Phosphatidylinositol 3,4,5-Trisphosphate (PIP3) Phosphatase, Skeletal Muscle, and Kidney Enriched Inositol Polyphosphate Phosphatase (SKIP)
- (2012) Takeshi Ijuin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GLUT4 exocytosis
- (2012) Jacqueline Stöckli et al. JOURNAL OF CELL SCIENCE
- mTOR Complex 2 Regulates Proper Turnover of Insulin Receptor Substrate-1 via the Ubiquitin Ligase Subunit Fbw8
- (2012) Sung Jin Kim et al. MOLECULAR CELL
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
- (2012) Geltrude Mingrone et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation
- (2012) P. Dalle Pezze et al. Science Signaling
- Amino acids and mTORC1: from lysosomes to disease
- (2012) Alejo Efeyan et al. TRENDS IN MOLECULAR MEDICINE
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
- (2011) Brian Magnuson et al. BIOCHEMICAL JOURNAL
- A Hierarchical Whole-body Modeling Approach Elucidates the Link betweenin VitroInsulin Signaling andin VivoGlucose Homeostasis
- (2011) Elin Nyman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of GSK3 by Wnt signalling - two contrasting models
- (2011) C. Metcalfe et al. JOURNAL OF CELL SCIENCE
- The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia
- (2011) L Willems et al. LEUKEMIA
- Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation
- (2011) S. Shin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Computational Modeling and Analysis of Insulin Induced Eukaryotic Translation Initiation
- (2011) Joshua Lequieu et al. PLoS Computational Biology
- FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and Rictor
- (2010) Chia-Chen Chen et al. DEVELOPMENTAL CELL
- Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework
- (2010) Cecilia Brännmark et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A spatial model of cellular molecular trafficking including active transport along microtubules
- (2010) A. Cangiani et al. JOURNAL OF THEORETICAL BIOLOGY
- Spatio-temporal modelling of the Hes1 and p53-Mdm2 intracellular signalling pathways
- (2010) Marc Sturrock et al. JOURNAL OF THEORETICAL BIOLOGY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
- (2010) C A Sparks et al. ONCOGENE
- A complex interplay between Akt, TSC2 and the two mTOR complexes: Figure 1
- (2009) Jingxiang Huang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- mTOR and cancer: many loops in one pathway
- (2009) Alejo Efeyan et al. CURRENT OPINION IN CELL BIOLOGY
- Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
- (2009) S. Park et al. HAEMATOLOGICA
- mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling
- (2009) L.-A. Julien et al. MOLECULAR AND CELLULAR BIOLOGY
- Harmonic oscillator model of the insulin and IGF1 receptors’ allosteric binding and activation
- (2009) Vladislav V Kiselyov et al. Molecular Systems Biology
- Toward a microscopic model of bidirectional synaptic plasticity
- (2009) G. C. Castellani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
- (2009) B. Schoeberl et al. Science Signaling
- TOR complex 2: a signaling pathway of its own
- (2009) Nadine Cybulski et al. TRENDS IN BIOCHEMICAL SCIENCES
- Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
- (2009) Morris E Feldman et al. PLOS BIOLOGY
- The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2
- (2008) J. Huang et al. MOLECULAR AND CELLULAR BIOLOGY
- Substrate selection by the proteasome during degradation of protein complexes
- (2008) Sumit Prakash et al. Nature Chemical Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started